6-K

HOLDING(S) IN COMPANY

Company: Indivior Pharmaceuticals, Inc.
Filed: November 18, 2024
Period of Report: November 18, 2024
Accession Number: 0001654954-24-014579

View Document ↗ View on SEC.gov ↗